← Leaderboards
Prasun Guha
University Of Nevada Las Vegas
$879,556
Attributed
$879,556
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $356.7K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$879,556 · 3
By mechanism
P20$504,591 · 2
R16$374,965 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Phosphotransferases”
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,064,669
- Richard Joseph Johnson · Colorado Research Partners, Llc$6,102,731
- Barry Hart · Innovation Pathways, Llc$5,485,474
- Timothy R Siegert · Allyx Biosciences, Inc.$5,367,450
- Frederic Geissmann · Sloan-Kettering Inst Can Research$5,019,765
- Sergi Regot · Johns Hopkins University$4,731,766
Research focus
PhosphotransferasesBiochemicalMolecularPathway InteractionsAffectCell ProliferationInositol Polyphosphate MultikinaseMediatingAmino AcidsMutantSignal TransductionCarcinoid TumorBiologicalCellsGeneticImpairmentLinkCell NucleusEmbryoCell CompartmentationEndosomesBiological ProcessElementsExperimental Study
Grant awards (4)
IPMK is a novel PI3k essential for mTORC2 activation and cell migration$187,746
R16 · FY2025 · GM · contact PI
IPMK is a novel PI3k essential for mTORC2 activation and cell migration$187,219
R16 · FY2024 · GM · contact PI
Role of IPMK in generation of small intestinal carcinoid$356,678
P20 · FY2022 · GM · contact PI
Role of IPMK in generation of small intestinal carcinoid$147,913
P20 · FY2021 · GM · contact PI